Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.38 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.35 |
| ▸ | HTR4 | Q13639 | 3/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27374719 | 0.89 | CA14 (0.36) | L3MBTL1PPARDPPARASCN3AHTR4 | |
| SCHEMBL29900237 | 0.89 | PPARD (0.38) | L3MBTL1PPARDPPARASCN3AHTR4 | |
| SCHEMBL27321821 | 0.88 | SCN3A (0.37) | PPARDPPARASCN3AHTR4ROCK2 | |
| SCHEMBL25371226 | 0.86 | L3MBTL1 (0.35) | L3MBTL1PPARDPPARASCN3AHTR4 | |
| SCHEMBL25371224 | 0.86 | L3MBTL1 (0.35) | L3MBTL1PPARDPPARASCN3AHTR4 | |
| SCHEMBL30869094 | 0.86 | SCN3A (0.38) | PPARDPPARASCN3AROCK2HCRTR1 | |
| SCHEMBL30694800 | 0.86 | CA14 (0.40) | PPARDPPARASCN3AROCK2CA14 | |
| SCHEMBL26049694 | 0.86 | CA14 (0.40) | PPARDPPARASCN3AROCK2CA14 | |
| SCHEMBL29900268 | 0.85 | SCN3A (0.39) | PPARDPPARASCN3AROCK2CA14 | |
| SCHEMBL26048981 | 0.85 | SCN3A (0.39) | PPARDPPARASCN3AROCK2CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |